Clinical Trials
Sponsor:
Sponsor Study ID:
Study Title:
A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors
NCT Number:
NCT03067181
Phase:
III
Protocol Type:
Treatment
Age Group:
Both
Disease Sites:
Other Female Genital, Other Male Genital, Ovary
Study Objectives:
This partially randomized phase III trial studies how well active surveillance, bleomycin, carboplatin, etoposide, or cisplatin work in treating pediatric and adult patients with germ cell tumors. Active surveillance may help doctors to monitor subjects with low risk germ cell tumors after their tumor is removed. Drugs used in chemotherapy, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.
Study Documents
(MUSC NetID required for document access)